37098084|t|Relationship between postoperative biomarkers of neuronal injury and postoperative cognitive dysfunction: A meta-analysis.
37098084|a|Early biomarkers are needed to identify patients at risk of developing postoperative cognitive dysfunction (POCD). Our objective was to determine neuronal injury-related biomarkers with predictive values for this condition. Six biomarkers (S100beta, neuron-specific enolase [NSE], amyloid beta [Abeta], tau, neurofilament light chain, and glial fibrillary acidic protein) were evaluated. According to the first postoperative sampling time, observational studies showed that S100beta was significantly higher in patients with POCD than in those without POCD (standardized mean difference [SMD]: 6.92, 95% confidence interval [CI]: 4.44-9.41). The randomized controlled trial (RCT) showed that S100beta (SMD: 37.31, 95% CI: 30.97-43.64) and NSE (SMD: 3.50, 95% CI: 2.71-4.28) in the POCD group were significantly higher than in the non-POCD group. The pooled data of observational studies by postoperative sampling time showed significantly higher levels of the following biomarkers in the POCD groups than in the control groups: S100beta levels at 1 hour (SMD: 1.35, 95% CI: 0.07-2.64), 2 days (SMD: 27.97, 95% CI: 25.01-30.94), and 9 days (SMD: 6.41, 95% CI: 5.64-7.19); NSE levels at 1 hour (SMD: 0.92, 95% CI: 0.25-1.60), 6 hours (SMD: 0.79, 95% CI: 0.12-1.45), and 24 hours (SMD: 0.84, 95% CI: 0.38-1.29); and Abeta levels at 24 hours (SMD: 2.30, 95% CI: 1.54-3.06), 2 days (SMD: 2.30, 95% CI: 1.83-2.78), and 9 days (SMD: 2.76, 95% CI: 2.25-3.26). The pooled data of the RCT showed that the following biomarkers were significantly higher in POCD patients than in non-POCD patients: S100beta levels at 2 days (SMD: 37.31, 95% CI: 30.97-43.64) and 9 days (SMD: 126.37, 95% CI: 104.97-147.76) and NSE levels at 2 days (SMD: 3.50, 95% CI: 2.71-4.28) and 9 days (SMD: 8.53, 95% CI: 7.00-10.06). High postoperative levels of S100beta, NSE, and Abeta may predict POCD. The relationship between these biomarkers and POCD may be affected by sampling time.
37098084	49	64	neuronal injury	Disease	MESH:D009410
37098084	69	104	postoperative cognitive dysfunction	Disease	MESH:D000079690
37098084	163	171	patients	Species	9606
37098084	194	229	postoperative cognitive dysfunction	Disease	MESH:D000079690
37098084	231	235	POCD	Disease	MESH:D000079690
37098084	269	284	neuronal injury	Disease	MESH:D009410
37098084	363	371	S100beta	Gene	6285
37098084	373	396	neuron-specific enolase	Gene	2026
37098084	398	401	NSE	Gene	2026
37098084	404	416	amyloid beta	Gene	351
37098084	418	423	Abeta	Gene	351
37098084	426	429	tau	Gene	4137
37098084	462	493	glial fibrillary acidic protein	Gene	2670
37098084	597	605	S100beta	Gene	6285
37098084	634	642	patients	Species	9606
37098084	648	652	POCD	Disease	MESH:D000079690
37098084	675	679	POCD	Disease	MESH:D000079690
37098084	815	823	S100beta	Gene	6285
37098084	862	865	NSE	Gene	2026
37098084	904	908	POCD	Disease	MESH:D000079690
37098084	957	961	POCD	Disease	MESH:D000079690
37098084	1111	1115	POCD	Disease	MESH:D000079690
37098084	1151	1159	S100beta	Gene	6285
37098084	1294	1297	NSE	Gene	2026
37098084	1436	1441	Abeta	Gene	351
37098084	1668	1672	POCD	Disease	MESH:D000079690
37098084	1673	1681	patients	Species	9606
37098084	1694	1698	POCD	Disease	MESH:D000079690
37098084	1699	1707	patients	Species	9606
37098084	1709	1717	S100beta	Gene	6285
37098084	1821	1824	NSE	Gene	2026
37098084	1946	1954	S100beta	Gene	6285
37098084	1956	1959	NSE	Gene	2026
37098084	1965	1970	Abeta	Gene	351
37098084	1983	1987	POCD	Disease	MESH:D000079690
37098084	2035	2039	POCD	Disease	MESH:D000079690
37098084	Positive_Correlation	MESH:D000079690	2026
37098084	Positive_Correlation	MESH:D000079690	6285

